Srikanth Vallurupalli
Concepts (287)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Artery Disease | 11 | 2022 | 321 | 4.020 |
Why?
| Atrial Fibrillation | 5 | 2022 | 185 | 2.670 |
Why?
| Percutaneous Coronary Intervention | 9 | 2022 | 335 | 2.590 |
Why?
| Ventricular Dysfunction, Right | 3 | 2023 | 32 | 2.560 |
Why?
| Aortic Valve Stenosis | 5 | 2021 | 75 | 2.370 |
Why?
| Ventricular Function, Right | 5 | 2023 | 44 | 2.320 |
Why?
| Stents | 8 | 2022 | 370 | 2.220 |
Why?
| Angioplasty, Balloon, Coronary | 4 | 2018 | 159 | 2.150 |
Why?
| Echocardiography | 11 | 2021 | 374 | 2.030 |
Why?
| Endocarditis | 2 | 2022 | 30 | 1.500 |
Why?
| Aortic Valve | 3 | 2020 | 113 | 1.480 |
Why?
| Thrombocytopenia | 2 | 2022 | 98 | 1.440 |
Why?
| Treatment Outcome | 25 | 2022 | 5645 | 1.310 |
Why?
| Myocardial Infarction | 4 | 2022 | 424 | 1.300 |
Why?
| Fractional Flow Reserve, Myocardial | 4 | 2022 | 142 | 1.230 |
Why?
| Heart Failure | 6 | 2022 | 492 | 1.200 |
Why?
| Ischemic Attack, Transient | 2 | 2018 | 58 | 1.190 |
Why?
| Humans | 65 | 2023 | 53836 | 1.190 |
Why?
| Electrocardiography | 5 | 2022 | 286 | 1.130 |
Why?
| Veterans | 2 | 2022 | 622 | 1.050 |
Why?
| Stroke | 3 | 2021 | 511 | 1.020 |
Why?
| Coronary Stenosis | 2 | 2021 | 107 | 0.930 |
Why?
| Coronary Angiography | 9 | 2022 | 390 | 0.900 |
Why?
| Risk Factors | 16 | 2022 | 3958 | 0.880 |
Why?
| Endocarditis, Bacterial | 1 | 2022 | 40 | 0.860 |
Why?
| Electric Countershock | 1 | 2022 | 33 | 0.860 |
Why?
| Atrial Appendage | 1 | 2021 | 19 | 0.830 |
Why?
| Anemia | 1 | 2022 | 89 | 0.820 |
Why?
| Catheter Ablation | 2 | 2021 | 131 | 0.810 |
Why?
| Anticholesteremic Agents | 1 | 2021 | 36 | 0.810 |
Why?
| Pulmonary Artery | 1 | 2022 | 150 | 0.800 |
Why?
| Hypercholesterolemia | 1 | 2021 | 43 | 0.800 |
Why?
| Kidney Diseases | 3 | 2021 | 291 | 0.790 |
Why?
| Cryosurgery | 1 | 2021 | 37 | 0.780 |
Why?
| Systole | 4 | 2023 | 77 | 0.770 |
Why?
| Magnetic Resonance Imaging, Cine | 3 | 2016 | 65 | 0.760 |
Why?
| Operative Time | 2 | 2017 | 78 | 0.750 |
Why?
| Dyspnea | 3 | 2018 | 81 | 0.740 |
Why?
| Digitalis | 1 | 2019 | 4 | 0.740 |
Why?
| Exercise Test | 2 | 2022 | 138 | 0.730 |
Why?
| Heart | 2 | 2021 | 352 | 0.720 |
Why?
| Anticoagulants | 3 | 2022 | 268 | 0.710 |
Why?
| Retrospective Studies | 15 | 2023 | 6330 | 0.710 |
Why?
| Predictive Value of Tests | 10 | 2022 | 1057 | 0.700 |
Why?
| Male | 31 | 2022 | 27633 | 0.690 |
Why?
| Thrombosis | 2 | 2022 | 239 | 0.680 |
Why?
| Aged | 20 | 2022 | 10151 | 0.670 |
Why?
| Cardiac Catheters | 1 | 2018 | 13 | 0.660 |
Why?
| Auscultation | 1 | 2018 | 9 | 0.660 |
Why?
| Heart Murmurs | 1 | 2018 | 15 | 0.660 |
Why?
| Asymptomatic Diseases | 1 | 2018 | 43 | 0.650 |
Why?
| Drug Prescriptions | 1 | 2018 | 87 | 0.640 |
Why?
| Artifacts | 1 | 2017 | 58 | 0.620 |
Why?
| Female | 28 | 2022 | 28727 | 0.620 |
Why?
| Heart Diseases | 2 | 2017 | 232 | 0.610 |
Why?
| Coronary Disease | 2 | 2015 | 155 | 0.610 |
Why?
| Middle Aged | 21 | 2020 | 13217 | 0.610 |
Why?
| Mediastinal Neoplasms | 1 | 2017 | 20 | 0.600 |
Why?
| Peripheral Arterial Disease | 1 | 2018 | 87 | 0.590 |
Why?
| Echocardiography, Doppler | 1 | 2017 | 61 | 0.590 |
Why?
| Time Factors | 9 | 2022 | 3282 | 0.590 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 150 | 0.590 |
Why?
| Coronary Occlusion | 1 | 2017 | 80 | 0.580 |
Why?
| Hospital Mortality | 2 | 2018 | 463 | 0.580 |
Why?
| Absorbable Implants | 1 | 2016 | 16 | 0.580 |
Why?
| Surgical Procedures, Operative | 1 | 2017 | 81 | 0.570 |
Why?
| Pneumonia | 1 | 2017 | 129 | 0.560 |
Why?
| Acute Coronary Syndrome | 1 | 2017 | 91 | 0.550 |
Why?
| Tomography, Optical Coherence | 1 | 2017 | 149 | 0.550 |
Why?
| Propafenone | 1 | 2015 | 2 | 0.550 |
Why?
| Tachycardia, Ectopic Atrial | 1 | 2015 | 3 | 0.550 |
Why?
| Flecainide | 1 | 2015 | 6 | 0.550 |
Why?
| Heart Conduction System | 1 | 2015 | 24 | 0.540 |
Why?
| Hypoparathyroidism | 1 | 2015 | 9 | 0.540 |
Why?
| Respiratory Insufficiency | 1 | 2017 | 123 | 0.540 |
Why?
| Rhabdomyolysis | 1 | 2015 | 13 | 0.540 |
Why?
| Hypocalcemia | 1 | 2015 | 14 | 0.530 |
Why?
| Heart Rate | 2 | 2021 | 350 | 0.510 |
Why?
| Clinical Competence | 1 | 2018 | 452 | 0.510 |
Why?
| Cardiac Surgical Procedures | 2 | 2017 | 318 | 0.500 |
Why?
| Heart Neoplasms | 1 | 2014 | 31 | 0.490 |
Why?
| Fibroma | 1 | 2014 | 42 | 0.490 |
Why?
| Thyroidectomy | 1 | 2015 | 101 | 0.490 |
Why?
| Physician-Patient Relations | 1 | 2015 | 154 | 0.490 |
Why?
| Ventricular Function, Left | 4 | 2019 | 175 | 0.480 |
Why?
| Theophylline | 1 | 2013 | 22 | 0.470 |
Why?
| Recurrence | 4 | 2021 | 695 | 0.470 |
Why?
| Diabetes Mellitus, Type 2 | 4 | 2022 | 481 | 0.460 |
Why?
| Syncope | 1 | 2013 | 31 | 0.460 |
Why?
| Physicians | 1 | 2015 | 253 | 0.410 |
Why?
| Amyloidosis | 3 | 2016 | 80 | 0.390 |
Why?
| Sulfonylurea Compounds | 1 | 2010 | 2 | 0.380 |
Why?
| Octreotide | 1 | 2010 | 16 | 0.380 |
Why?
| Benzocaine | 1 | 2009 | 5 | 0.370 |
Why?
| Arkansas | 6 | 2019 | 2158 | 0.370 |
Why?
| Ventricular Remodeling | 3 | 2021 | 64 | 0.370 |
Why?
| Methemoglobinemia | 1 | 2009 | 7 | 0.360 |
Why?
| Prognosis | 5 | 2022 | 2115 | 0.360 |
Why?
| Head and Neck Neoplasms | 1 | 2013 | 326 | 0.360 |
Why?
| Hypoglycemia | 1 | 2010 | 61 | 0.360 |
Why?
| Echocardiography, Transesophageal | 1 | 2009 | 73 | 0.350 |
Why?
| Anesthetics, Local | 1 | 2009 | 75 | 0.350 |
Why?
| Diagnosis, Differential | 3 | 2018 | 1139 | 0.340 |
Why?
| Stroke Volume | 2 | 2019 | 138 | 0.340 |
Why?
| Prosthesis Design | 3 | 2022 | 263 | 0.320 |
Why?
| Prospective Studies | 3 | 2023 | 2569 | 0.320 |
Why?
| Vasodilator Agents | 2 | 2022 | 108 | 0.320 |
Why?
| Myocardial Contraction | 2 | 2019 | 114 | 0.320 |
Why?
| Incidence | 5 | 2019 | 1074 | 0.310 |
Why?
| Coronary Vessels | 2 | 2020 | 185 | 0.290 |
Why?
| Heart Ventricles | 4 | 2022 | 268 | 0.290 |
Why?
| Pressure | 2 | 2017 | 122 | 0.290 |
Why?
| Chronic Disease | 3 | 2018 | 623 | 0.280 |
Why?
| Defibrillators, Implantable | 2 | 2019 | 63 | 0.280 |
Why?
| Randomized Controlled Trials as Topic | 5 | 2022 | 577 | 0.260 |
Why?
| Reproducibility of Results | 2 | 2021 | 1306 | 0.260 |
Why?
| Cardiomyopathies | 2 | 2016 | 111 | 0.260 |
Why?
| Foramen Ovale, Patent | 2 | 2015 | 28 | 0.260 |
Why?
| Follow-Up Studies | 5 | 2019 | 2376 | 0.250 |
Why?
| Hepatitis C, Chronic | 2 | 2015 | 92 | 0.250 |
Why?
| Hospitalization | 4 | 2022 | 687 | 0.230 |
Why?
| Bioprosthesis | 1 | 2022 | 30 | 0.220 |
Why?
| Electrodes | 1 | 2022 | 38 | 0.220 |
Why?
| Risk Assessment | 4 | 2022 | 1375 | 0.220 |
Why?
| Proportional Hazards Models | 3 | 2020 | 433 | 0.210 |
Why?
| Warfarin | 1 | 2022 | 86 | 0.210 |
Why?
| Adult | 8 | 2018 | 14303 | 0.210 |
Why?
| Multiple Myeloma | 4 | 2017 | 2923 | 0.210 |
Why?
| Sodium-Glucose Transporter 1 | 1 | 2020 | 5 | 0.200 |
Why?
| Glycosides | 1 | 2020 | 16 | 0.200 |
Why?
| Cardiac Catheterization | 2 | 2022 | 240 | 0.200 |
Why?
| Microscopy, Fluorescence, Multiphoton | 1 | 2020 | 8 | 0.200 |
Why?
| Pilot Projects | 2 | 2022 | 815 | 0.200 |
Why?
| Heart Valve Prosthesis Implantation | 1 | 2022 | 90 | 0.200 |
Why?
| Heart Valve Prosthesis | 1 | 2022 | 93 | 0.200 |
Why?
| Vasodilation | 1 | 2021 | 105 | 0.200 |
Why?
| Tachycardia, Supraventricular | 1 | 2021 | 37 | 0.200 |
Why?
| Severity of Illness Index | 2 | 2018 | 1087 | 0.200 |
Why?
| Cardiovascular System | 1 | 2020 | 48 | 0.200 |
Why?
| Calcinosis | 1 | 2020 | 58 | 0.190 |
Why?
| United States Department of Veterans Affairs | 1 | 2022 | 318 | 0.190 |
Why?
| United States | 3 | 2022 | 5162 | 0.190 |
Why?
| Digoxin | 1 | 2019 | 23 | 0.180 |
Why?
| Heart Failure, Systolic | 1 | 2019 | 7 | 0.180 |
Why?
| Blood Pressure | 1 | 2022 | 575 | 0.180 |
Why?
| Electric Stimulation Therapy | 1 | 2019 | 24 | 0.180 |
Why?
| Metoprolol | 1 | 2019 | 13 | 0.170 |
Why?
| Inpatients | 2 | 2018 | 209 | 0.170 |
Why?
| Cardiotonic Agents | 1 | 2019 | 79 | 0.170 |
Why?
| Platelet Transfusion | 1 | 2018 | 31 | 0.170 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 517 | 0.170 |
Why?
| Cerebrovascular Disorders | 1 | 2018 | 54 | 0.170 |
Why?
| Hepatitis C Antibodies | 2 | 2015 | 23 | 0.160 |
Why?
| Delivery of Health Care | 1 | 2021 | 302 | 0.160 |
Why?
| Databases, Factual | 2 | 2018 | 696 | 0.160 |
Why?
| Cardiac Imaging Techniques | 1 | 2017 | 7 | 0.160 |
Why?
| Renal Insufficiency, Chronic | 1 | 2020 | 177 | 0.160 |
Why?
| Cardiovascular Diseases | 3 | 2020 | 477 | 0.160 |
Why?
| Cell Transdifferentiation | 1 | 2017 | 7 | 0.150 |
Why?
| Fever | 1 | 2018 | 126 | 0.150 |
Why?
| Xanthine Oxidase | 1 | 2017 | 16 | 0.150 |
Why?
| Foam Cells | 1 | 2017 | 16 | 0.150 |
Why?
| Hepacivirus | 2 | 2015 | 127 | 0.150 |
Why?
| Logistic Models | 2 | 2017 | 1002 | 0.150 |
Why?
| Hemorrhage | 1 | 2018 | 192 | 0.150 |
Why?
| Respiratory Sounds | 1 | 2017 | 54 | 0.150 |
Why?
| Myocytes, Smooth Muscle | 1 | 2017 | 91 | 0.150 |
Why?
| Radiographic Image Enhancement | 1 | 2016 | 31 | 0.150 |
Why?
| Survival Rate | 2 | 2019 | 974 | 0.150 |
Why?
| Propensity Score | 1 | 2017 | 136 | 0.150 |
Why?
| Inflammasomes | 1 | 2017 | 61 | 0.150 |
Why?
| Gadolinium DTPA | 1 | 2016 | 33 | 0.140 |
Why?
| Cohort Studies | 2 | 2018 | 1548 | 0.140 |
Why?
| Chi-Square Distribution | 1 | 2017 | 327 | 0.140 |
Why?
| Muscle, Smooth, Vascular | 1 | 2017 | 140 | 0.140 |
Why?
| Quality Improvement | 1 | 2018 | 238 | 0.140 |
Why?
| Voltage-Gated Sodium Channel Blockers | 1 | 2015 | 8 | 0.140 |
Why?
| Intermittent Claudication | 1 | 2015 | 12 | 0.140 |
Why?
| Ventricular Function | 1 | 2015 | 19 | 0.140 |
Why?
| Fundoplication | 1 | 2015 | 21 | 0.140 |
Why?
| Goiter | 1 | 2015 | 6 | 0.140 |
Why?
| Healthcare Disparities | 1 | 2018 | 259 | 0.140 |
Why?
| Pericardiectomy | 1 | 2015 | 4 | 0.140 |
Why?
| Postpericardiotomy Syndrome | 1 | 2015 | 4 | 0.140 |
Why?
| Immobilization | 1 | 2015 | 14 | 0.130 |
Why?
| Supine Position | 1 | 2015 | 34 | 0.130 |
Why?
| Kidney | 1 | 2020 | 828 | 0.130 |
Why?
| Mucolipidoses | 1 | 2014 | 4 | 0.130 |
Why?
| Pericarditis | 1 | 2015 | 22 | 0.130 |
Why?
| Length of Stay | 1 | 2018 | 693 | 0.130 |
Why?
| Colchicine | 1 | 2015 | 36 | 0.130 |
Why?
| Secondary Prevention | 1 | 2015 | 88 | 0.130 |
Why?
| Aged, 80 and over | 3 | 2018 | 3506 | 0.130 |
Why?
| Scavenger Receptors, Class E | 1 | 2017 | 219 | 0.130 |
Why?
| Thoracotomy | 1 | 2014 | 38 | 0.120 |
Why?
| Obesity, Morbid | 1 | 2015 | 88 | 0.120 |
Why?
| Sulfonamides | 1 | 2015 | 151 | 0.120 |
Why?
| Septal Occluder Device | 1 | 2014 | 29 | 0.120 |
Why?
| Carcinoma, Renal Cell | 1 | 2015 | 122 | 0.120 |
Why?
| Pyrimidines | 1 | 2015 | 199 | 0.120 |
Why?
| Bone Marrow Transplantation | 1 | 2014 | 130 | 0.120 |
Why?
| Kidney Neoplasms | 1 | 2015 | 198 | 0.120 |
Why?
| Laparoscopy | 1 | 2015 | 184 | 0.120 |
Why?
| Administration, Oral | 1 | 2013 | 468 | 0.110 |
Why?
| Tomography, X-Ray Computed | 1 | 2017 | 1204 | 0.100 |
Why?
| Postoperative Complications | 2 | 2015 | 1055 | 0.100 |
Why?
| Magnetic Resonance Imaging | 2 | 2017 | 1640 | 0.100 |
Why?
| Injections, Subcutaneous | 1 | 2010 | 60 | 0.090 |
Why?
| Pericardium | 1 | 2010 | 28 | 0.090 |
Why?
| Gastrointestinal Agents | 1 | 2010 | 38 | 0.090 |
Why?
| Drug Monitoring | 1 | 2010 | 86 | 0.090 |
Why?
| Cause of Death | 2 | 2020 | 154 | 0.090 |
Why?
| Quality of Life | 1 | 2015 | 899 | 0.090 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1049 | 0.090 |
Why?
| Lipid Metabolism | 1 | 2010 | 204 | 0.080 |
Why?
| Renal Dialysis | 1 | 2010 | 193 | 0.080 |
Why?
| Kidney Failure, Chronic | 1 | 2010 | 225 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 1 | 2010 | 1518 | 0.070 |
Why?
| Exercise | 1 | 2010 | 531 | 0.070 |
Why?
| Disease Progression | 2 | 2020 | 911 | 0.070 |
Why?
| RNA, Viral | 2 | 2015 | 140 | 0.060 |
Why?
| Oxidative Stress | 1 | 2010 | 955 | 0.060 |
Why?
| Vitamin K | 1 | 2022 | 17 | 0.060 |
Why?
| American Heart Association | 1 | 2022 | 38 | 0.060 |
Why?
| Mitral Valve | 1 | 2022 | 69 | 0.050 |
Why?
| Prosthesis Failure | 1 | 2022 | 118 | 0.050 |
Why?
| Telemetry | 1 | 2021 | 36 | 0.050 |
Why?
| Glucosides | 1 | 2020 | 15 | 0.050 |
Why?
| Tachycardia | 1 | 2021 | 32 | 0.050 |
Why?
| Diabetic Ketoacidosis | 1 | 2020 | 17 | 0.050 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2022 | 177 | 0.050 |
Why?
| Acute Disease | 1 | 2022 | 407 | 0.050 |
Why?
| Glomerular Filtration Rate | 1 | 2020 | 139 | 0.050 |
Why?
| Early Diagnosis | 1 | 2020 | 97 | 0.050 |
Why?
| Benzhydryl Compounds | 1 | 2020 | 74 | 0.050 |
Why?
| Exercise Tolerance | 1 | 2019 | 43 | 0.040 |
Why?
| Death, Sudden, Cardiac | 1 | 2019 | 54 | 0.040 |
Why?
| Feasibility Studies | 1 | 2020 | 401 | 0.040 |
Why?
| Anti-Arrhythmia Agents | 1 | 2019 | 86 | 0.040 |
Why?
| Adrenergic beta-Antagonists | 1 | 2019 | 104 | 0.040 |
Why?
| Oxygen Consumption | 1 | 2019 | 229 | 0.040 |
Why?
| Recovery of Function | 1 | 2019 | 224 | 0.040 |
Why?
| Uric Acid | 1 | 2017 | 32 | 0.040 |
Why?
| Registries | 1 | 2020 | 548 | 0.040 |
Why?
| Scavenger Receptors, Class A | 1 | 2017 | 39 | 0.040 |
Why?
| Referral and Consultation | 1 | 2018 | 313 | 0.040 |
Why?
| RNA Interference | 1 | 2017 | 200 | 0.040 |
Why?
| Transfection | 1 | 2017 | 417 | 0.040 |
Why?
| Hernia, Hiatal | 1 | 2015 | 12 | 0.030 |
Why?
| Biopsy, Needle | 1 | 2016 | 197 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 262 | 0.030 |
Why?
| Gastroesophageal Reflux | 1 | 2015 | 51 | 0.030 |
Why?
| Patient Acceptance of Health Care | 1 | 2018 | 333 | 0.030 |
Why?
| Tubulin Modulators | 1 | 2015 | 40 | 0.030 |
Why?
| Indazoles | 1 | 2015 | 57 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2020 | 2028 | 0.030 |
Why?
| Seroepidemiologic Studies | 1 | 2014 | 53 | 0.030 |
Why?
| Disease Models, Animal | 1 | 2020 | 1684 | 0.030 |
Why?
| Reactive Oxygen Species | 1 | 2017 | 494 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2016 | 645 | 0.030 |
Why?
| Pneumonectomy | 1 | 2014 | 27 | 0.030 |
Why?
| Survival Analysis | 1 | 2016 | 746 | 0.030 |
Why?
| Biopsy | 1 | 2016 | 679 | 0.030 |
Why?
| Prosthesis Implantation | 1 | 2014 | 47 | 0.030 |
Why?
| Myocardium | 1 | 2016 | 441 | 0.030 |
Why?
| Posture | 1 | 2014 | 81 | 0.030 |
Why?
| Angiogenesis Inhibitors | 1 | 2015 | 205 | 0.030 |
Why?
| Anti-Inflammatory Agents | 1 | 2015 | 182 | 0.030 |
Why?
| Syndrome | 1 | 2014 | 250 | 0.030 |
Why?
| Age Distribution | 1 | 2013 | 206 | 0.030 |
Why?
| Ventricular Dysfunction, Left | 1 | 2014 | 94 | 0.030 |
Why?
| Immunohistochemistry | 1 | 2016 | 1109 | 0.030 |
Why?
| Polymerase Chain Reaction | 1 | 2014 | 539 | 0.030 |
Why?
| Transplantation, Autologous | 1 | 2014 | 452 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2017 | 1546 | 0.030 |
Why?
| Comorbidity | 1 | 2013 | 684 | 0.030 |
Why?
| Oxygen | 1 | 2014 | 367 | 0.020 |
Why?
| alpha-2-HS-Glycoprotein | 1 | 2010 | 1 | 0.020 |
Why?
| Thiobarbituric Acid Reactive Substances | 1 | 2010 | 12 | 0.020 |
Why?
| Blood Proteins | 1 | 2010 | 106 | 0.020 |
Why?
| Signal Transduction | 1 | 2017 | 1793 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2010 | 151 | 0.020 |
Why?
| Interleukin-6 | 1 | 2010 | 313 | 0.020 |
Why?
| Lung Neoplasms | 1 | 2014 | 620 | 0.020 |
Why?
| Animals | 1 | 2020 | 14624 | 0.020 |
Why?
| Young Adult | 1 | 2013 | 4356 | 0.010 |
Why?
| Adolescent | 1 | 2013 | 6918 | 0.010 |
Why?
|
|
Vallurupalli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|